Marpai, Inc.

MRAI Healthcare Healthcare Plans

Marpai, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.1 million, down 35.8% from fiscal 2024. In the quarter to June 2026, revenue fell 10.5%, EPS grew 35.7%, free cash flow fell 27.7% and total debt fell 20.3%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

3.13 0.06 −1.88%
Market cap
$5.2M
P/E
0.0×
Fwd P/E
−3.3×
Dividend yield
—
F-score
2/9
Altman Z
−18.80
Beneish M
−6.73
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
2 2 2 3

+8 more TTM periods

ROE
47.39% 50.95% 54.95% 39.70%
ROA
(164.52%) (135.38%) (139.26%) (74.72%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
116.12% 99.75% 107.83% 113.01%
Average Days of Receivables
46.12 30.54 19.70 20.63
Free Cash Flow per Share
(0.34) (0.32) (0.43) (0.43)
Free Cash Flow
(8.70) (7.81) (7.45) (7.37)
Other line items

Show all line items

Columns are period end dates